The Effect of Usual Dose Rosuvastatin Plue Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque: A Randomized Controlled Trial

Trial Profile

The Effect of Usual Dose Rosuvastatin Plue Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque: A Randomized Controlled Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2017

At a glance

  • Drugs Ezetimibe/rosuvastatin (Primary) ; Rosuvastatin
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms Rosuzet-IVUS
  • Most Recent Events

    • 10 Oct 2017 Status changed from not yet recruiting to recruiting.
    • 02 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top